| Date | Title | Description | Source |
| 11.03.2024 | BioStock: BioInvent’s CEO comments on the study success in C... | BioStock: BioInvent’s CEO comments on the study success in China
Mon, Mar 11, 2024 12:31 CET Report ... | news.cisio... |
| 20.01.2022 | CASI PHARMACEUTICALS PARTNER, BIOINVENT, ANNOUNCES BI -1206 ... | ROCKVILLE, Md and LUND, Sweden, Jan. 20, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CA... | marketscre... |
| 18.01.2022 | CASI PHARMACEUTICALS ANNOUNCES CNCT19 (CD19 CAR-T) GRANTED O... | ROCKVILLE, Md. and BEIJING, Jan. 18, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI),... | marketscre... |
| 03.01.2022 | CASI PHARMACEUTICALS, RECEIVES NASDAQ DEFICIENCY NOTICE | ROCKVILLE, Md. and BEIJING, Jan. 3, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), ... | marketscre... |
| 17.12.2021 | CASI PHARMACEUTICALS ANNOUNCES STOCK REPURCHASE PROGRAM | ROCKVILLE, Md. and BEIJING, Dec. 17, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI),... | marketscre... |
| 17.12.2021 | CASI Pharmaceuticals, Inc. announces an Equity Buyback for $... | CASI Pharmaceuticals, Inc. (NasdaqCM:CASI) announces a share repurchase program. Under the program, ... | marketscre... |
| 10.12.2021 | CASI PHARMACEUTICALS AND BIOINVENT ANNOUNCE CTA APPROVAL FOR... | ROCKVILLE, Md. and BEIJING, Dec. 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI),... | marketscre... |
| 15.11.2021 | CASI Pharmaceuticals To Present At Jefferies London Healthca... | ROCKVILLE, Md., and BEIJING, Nov. 15, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI)... | marketscre... |
| 12.11.2021 | CASI Pharmaceuticals Announces Third Quarter 2021 Financial ... | ROCKVILLE, Md. and BEIJING, Nov. 12, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI),... | marketscre... |
| 26.10.2021 | CASI Pharmaceuticals Announces Partner Juventas Completion O... | ROCKVILLE, Md. and BEIJING - CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical com... | marketscre... |
| 25.10.2021 | CASI Pharmaceuticals Announces Partner Juventas Completio... | CASI Pharmaceuticals, Inc., a US biopharmaceutical company focused on developing and commercializing... | aithority.... |
| 25.10.2021 | CASI Pharmaceuticals : Pharmaceuticals Announces Partner ... | ROCKVILLE, Md. and BEIJING, Oct. 25, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI),... | marketscre... |
| 12.08.2021 | CASI Pharmaceuticals : Announces Second Quarter 2021 Financi... | ROCKVILLE, Md. and BEIJING, Aug. 12, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI),... | marketscre... |
| 12.08.2021 | CASI Pharmaceuticals Announces Second Quarter 2021 Financial... | | prnewswire... |
| 10.06.2021 | CASI Pharmaceuticals Announces Dosing Of First Patient Of CI... | | prnewswire... |
| 10.06.2021 | CASI PHARMACEUTICALS, INC.
CASI Pharmaceuticals : Announces... | CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Rela... | marketscre... |
| 08.06.2021 | CASI PHARMACEUTICALS, INC.
CASI Pharmaceuticals : 2021 Defi... | CASI PHARMACEUTICALS, INC.
SUPPLEMENT DATED JUNE 7, 2021
TO THE PROXY STATEMENT DATED MAY 10, 2021
F... | marketscre... |
| 13.05.2021 | CASI Pharmaceuticals Announces First Quarter 2021 Financial ... | | prnewswire... |
| 11.05.2021 | CASI PHARMACEUTICALS, INC.
CASI Pharmaceuticals : 2020 Form... | UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-K/A
(Amendment No. ... | marketscre... |
| 30.03.2021 | CASI Pharmaceuticals Announces Full Year 2020 Financial Resu... | | prnewswire... |
| 24.03.2021 | CASI Pharmaceuticals Announces Pricing Of $32,500,000 Public... | | prnewswire... |
| 23.03.2021 | CASI Pharmaceuticals Announces Proposed Public Offering Of C... | | prnewswire... |
| 16.02.2021 | CASI Pharmaceuticals Announces Preliminary Fourth Quarter An... | | prnewswire... |
| 28.01.2021 | CASI Pharmaceuticals Partner, BioInvent, Presents Phase I/II... | | prnewswire... |
| 21.01.2021 | CASI Pharmaceuticals Partner, BioInvent, To Host Key Opinion... | | prnewswire... |
| 08.01.2021 | CASI Pharmaceuticals, Inc. To Present At H.C. Wainwright Bio... | | prnewswire... |
| 23.12.2020 | CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives ... | | prnewswire... |
| 16.12.2020 | CASI Pharmaceuticals Announces Appointment Of Chief Financia... | | prnewswire... |
| 18.11.2020 | CASI Pharmaceuticals Announces Partner Juventas Completes $6... | | prnewswire... |
| 27.10.2020 | BioInvent licenses anti-FcγRllB antibody BI-1206 to CASI Pha... | | prnewswire... |
| 29.09.2020 | CASI Pharmaceuticals Announces Restructuring of Partnership ... | | prnewswire... |
| 17.06.2019 | A unicorn stalks Wall Street in search of IPO cash; CASI Ph... | → A herd of upstart biotechs will look to Wall Street for some major windfalls this week as a bur... | endpts.com... |
| 31.01.2019 | Multi-target drugs should be in the pharma pipeline along wi... | Precision medicine — providing the right treatment, for the right patient, at the right time — is sa... | statnews.c... |
| 17.09.2018 | Here’s a look at Maryland’s publicly-traded biotech companie... | When talk turns to Maryland’s biotech bonafides, the ideas and talent being produced by government i... | technical.... |
